1 Cost Effectiveness  Jan J.V. Busschbach, Ph.D.  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.

Slides:



Advertisements
Similar presentations
Johan Polder, PhD | Professor in Health Eonomics
Advertisements

ECONOMIC EVALUATION WHY DO YOU NEED TO BOTHER? JUDITH BOSMANS.
Penny Wise and Effect Size Foolish Greg J. Duncan Northwestern University.
COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
1 The QALYs debate  Prof. dr. Jan J.V. Busschbach, Ph.D.  Erasmus MC  Institute for Medical Psychology and Psychotherapy.
1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.
Crime Theories Causes of Crime. Focus Question Why do people commit crimes?
1 A Health Economic View on Borderline Personality Disorder Prof. dr. Jan Busschbach Viersprong Institute for studies on Personality Disorders Medical.
Chapter 26 The Economics of Crime Copyright © 2010 by The McGraw-Hill Companies, Inc. All rights reserved.McGraw-Hill/Irwin.
Economic Analysis and Management Todd Wagner, PhD.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
Steve Aos Assistant Director Washington State Institute for Public Policy Phone: (360) Institute Publications:
Setting a Context for Medicare Spending
Schneider Institute for Health Policy Heller Graduate School Brandeis University 1 by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller.
The Panel on Cost-Effectiveness in Health and Medicine Marthe Gold City University of London 30 October, 2003.
QALYs and Ethics Prof. dr. Jan van Busschbach 11.
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Implementing PMTO in The Nederlands Implementation study Nienke Bekkema Karin Wiefferink TNO Quality of Life.
America’s Drug Problem. Is Prison Time The Cure?.
Rising to the Challenge Spine 10 x 25 Initiative Research Summit North American Spine Foundation July 18, 2015 Dan Cherkin, PhD Group Health Research Institute.
QALYs and Ethics Is there an ethical / valid alternative?
Cost Effectiveness Analysis To Enhance Mammography Use Dave Alvey Paul Moley.
1 Cost-effectiveness in Personality Disorder Dr. J.J.V. Busschbach Psychotherapeutic centre ‘De Viersprong’ –PO Box AA Halsteren
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Measuring the Economic Impact of PLEI Research and Statistics Division Susan McDonald PLEAC, October 2012.
BIOE 301 Lecture Thirteen. HIV/AIDS Vaccine Update.
Lecture Thirteen Biomedical Engineering for Global Health.
Drug Offender Reform Act Smarter Sentencing + Smarter Treatment = Better Outcomes and Safer Neighborhoods.
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
Prevention and Early Intervention Linking Long-Term Vision with Short-Term Costs J effrey P oirier, B.A. M ary M agee Q uinn, Ph.D. American Institutes.
Rebecca A. Maynard, Ph.D. University of Pennsylvania December 1, 2009.
1 QALY, Burden of Disease and Budget Impact  Jan J.V. Busschbach, Ph.D.  Erasmus MC, Rotterdam, The Netherlands  
TREATMENT OF THE JUVENILE OFFENDER CONCLUSIONS FROM THEORY AND RESEARCH DR. ROBERT D. HOGE DEPARTMENT OF PSYCHOLOGY CARLETON UNIVERSITY OTTAWA, ONTARIO.
Incarceration, Reentry and Disparities in Health: What are the connections? Nicholas Freudenberg Hunter College, May 5, 2006 Presented at the Prisoner.
Predicting the Benefits and Costs of Criminal Justice Policies TAD Conference, August 23, 2013 David L. Weimer La Follette School of Public Affairs University.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 Cost effectiveness as argument for reimbursement in prevention Jan J. v. Busschbach, Ph.D. Erasmus MC –Institute for Medical Psychology and Psychotherapy.
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
1 The Economic Burden of Personality Disorders  Djøra Soeteman, Jan J.V. Busschbach, Leona Hakkaart-van Roijen, Roel Verheul  Viersprong Institute for.
McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 28 The Economics of Crime.
Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong.
11 Cost Effectiveness in Preventing Crime  Jan van Busschbach, Djøra Soeteman  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.
1 The Cost Effectiveness of Treatment of Personality Disorder  Dr. Jan J.V. Busschbach  PTC De Viersprong, Erasmus MC, Rotterdam, 
Cost-effectiveness in the quest to convince the outside world Dr. Jan Busschbach De Viersprong Erasmus MC
TECBD, 2003 Financial and Human Costs of Treatment or Failure to Provide Treatment Mary Quinn Jeffrey Poirier American Institutes for Research National.
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.
Preliminary Report Joint Legislative Audit and Review Committee Cynthia L. Forland September 14, 2005 At-Risk Youth Study.
Evidence-Based Prevention of Underage Drinking: An Overview Scott Caldwell Presentation to the Dane Co. Coalition to Reduce Alcohol Abuse March 31, 2009.
The financial costs and benefits of alcohol The financial costs and benefits of alcohol Christine Godfrey Department of Health Sciences & Centre for Health.
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
McGraw-Hill/Irwin © 2002 The McGraw-Hill Companies, Inc., All Rights Reserved. Chapter 24 The Economics of Crime.
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
BIOE 301 Lecture Sixteen. Review of Lectures What is the goal of cancer screening? Successful cancer screening examples? Can screening hurt more.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
1 Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
Presentation Developed for the Academy of Managed Care Pharmacy
F581 Economics. Demand & Supply Question  Impact depends upon the extent of the shift.  If demand shifts, the impact will depend on elasticity of supply.
Palliative Care with Older Adults Section 3: Policy Issues Related To Aging And Palliative Care Gunnar Almgren, PhD University of Washington, School of.
RESEARCH POSTER PRESENTATION DESIGN © There are approximately 500,000 foster youth in care at any given time in the United.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
POLICIES INVOLVING STRUCTURAL INTERVENTIONS TO REDUCE RISKS ASSOCIATED WITH HIV/AIDS IN COMMUNITIES OF COLOR IN CHICAGO, ILLINOIS William Ebomoyi, Ph.D.
Cost effectiveness Analysis: Valuing Health; Valuing Research!
University of Washington,
A Meta Analysis of the Impact of SBI on Healthcare Utilization
A Meta Analysis of the Impact of SBI on Healthcare Utilization
Justification treatment cost
Presentation transcript:

1 Cost Effectiveness  Jan J.V. Busschbach, Ph.D.  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus MC  Institute for Medical Psychology and Psychotherapy

2 (Health) Economics  Comparing different allocations  In health care: Should we spent our money on Wheel chairs Screening for cancer  Intervention in youth Jail Cure Prevention

3 Assumptions  Agreement on the budget  Assumption of scarcity  Agreement on outcome  What are the intended effects  Possible to moves between budgets

4 Economics in policy  Economics in policy are often  Only Better effects for the same (or less) money “Doelmatigheid”  Efficiency improvement  Budget impact

5 Car economics  Should we spend our money on a  Suzuki Alto 1.0  BMW 316

6 Car economics  Cost effectiveness  Comparing costs  Comparing outcome  Relate costs to outcome  Cost per outcome  Cost per kilometer

7 League Table

8 Assumptions  Agreement on the budget  Assumption of scarcity  Possible to moves between budgets  We can buy a Suzkie or a BMW  Agreement on outcome  What are the intended effects  The effects is restricted to ‘movement’

9 Which costs included in CE youth intervention?  Costs of intervention  Costs of alternatives  Jail  Other treatment  Costs of crime  Material costs  Cost of law enforcement  Other savings  Broken education  Intangible costs

10 Intangible costs  What are the costs of  Death  Suffering  Rape  Fear  No clear methodology  Willingness to pay

11 Which outcomes in youth interventions?  What is the aim of youth interventions?  Costs per avoided crime  Costs per contact  Prevention

12 Effects expressed as costs  Cost Benefit analysis  Effects can now be subtracted from costs

13 Drivers in health economics  The effect of the intervention  The cost of the intervention  Intangible costs  Discounting

14 Changes of economics in youth interventions  The effect of the intervention  The cost of the intervention  Alternative is expensive: Jail  Intangible costs  The effects are warranted  Broken education  Discounting  Sometime immediate effects

15 Threats of economics in youth interventions  The effect of the intervention  Low quality evidence on the effectiveness  A randomized trials is now the standard  The cost of the intervention  Expensive labour-intensive  Intangible costs  No consensus about these costs  Discounting  Often effect are in the further: prevention

16 Examples  The Washington State Institute for Public Policy  Steve Aos, 2004  Taxpayer perspective: cost benefit analysis  Intangible costs used as effects (sexual abuse = $ 94,506)  The monetary value of saving a high-risk youth  Cohen, 1998  Intangible costs: lifetime costs criminal career

17 Little studies  Welsh & Farrington, 2000  “[…] little is known about the economic efficiency of correctional intervention strategies. A review of the literature revealed only seven published studies that have presented information on monetary costs and benefits”.  Swaray et al, 2005  Found only 10 studies  The norm ‘evidence based’ is not near  Research dominated by aetiology and epidemiology

18 Encouraging results  Reviews show favorable results  Cure is more cost effective than prevention Targeted prevention works better  Cure more cost effective than incarceration  No Dutch evidence  Although The Netherlands is leading in health economics

19 Conclusion  Economics are lacking  Main obstacles  Convincible effect studies  The odds are favorable